175 related articles for article (PubMed ID: 37203233)
1. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK; Bergstrom J; Loomba R; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Truong E; Yang JD; Noureddin M; Allen AM; Loomba R; Ajmera V
Hepatology; 2023 Dec; 78(6):1858-1866. PubMed ID: 37203233
[TBL] [Abstract][Full Text] [Related]
2. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
[TBL] [Abstract][Full Text] [Related]
3. Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis.
Eaton JE; Sen A; Hoodeshenas S; Schleck CD; Harmsen WS; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1576-1583.e1. PubMed ID: 31683058
[TBL] [Abstract][Full Text] [Related]
4. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
5. Performance of magnetic resonance elastography in primary sclerosing cholangitis.
Eaton JE; Dzyubak B; Venkatesh SK; Smyrk TC; Gores GJ; Ehman RL; LaRusso NF; Gossard AA; Lazaridis KN
J Gastroenterol Hepatol; 2016 Jun; 31(6):1184-90. PubMed ID: 26691631
[TBL] [Abstract][Full Text] [Related]
6. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD.
Gidener T; Ahmed OT; Larson JJ; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Yin M; Allen AM
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1915-1924.e6. PubMed ID: 33010409
[TBL] [Abstract][Full Text] [Related]
7. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R
Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165
[TBL] [Abstract][Full Text] [Related]
8. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
9. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.
Tamaki N; Imajo K; Sharpton SR; Jung J; Sutter N; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Kurosaki M; Izumi N; Nakajima A; Loomba R
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):380-387.e3. PubMed ID: 35123096
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ; Noureddin N; Ajmera V; Amangurbanova M; Bettencourt R; Truong E; Gidener T; Siddiqi H; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Yoneda M; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Allen AM; Noureddin M; Loomba R
Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):829-836. PubMed ID: 37419133
[TBL] [Abstract][Full Text] [Related]
11. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.
Park JG; Jung J; Verma KK; Kang MK; Madamba E; Lopez S; Qas Yonan A; Liu A; Bettencourt R; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2021 May; 53(9):1030-1037. PubMed ID: 33764550
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Tamaki N; Imajo K; Sharpton S; Jung J; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
Hepatology; 2022 Mar; 75(3):661-672. PubMed ID: 34496054
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
Qu Y; Middleton MS; Loomba R; Glaser KJ; Chen J; Hooker JC; Wolfson T; Covarrubias Y; Valasek MA; Fowler KJ; Zhang YN; Sy E; Gamst AC; Wang K; Mamidipalli A; Schwimmer JB; Song B; Reeder SB; Yin M; Ehman RL; Sirlin CB
Eur Radiol; 2021 Nov; 31(11):8408-8419. PubMed ID: 33899143
[TBL] [Abstract][Full Text] [Related]
14. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
[TBL] [Abstract][Full Text] [Related]
15. Predicting gastroesophageal varices through spleen magnetic resonance elastography in pediatric liver fibrosis.
Yoon H; Shin HJ; Kim MJ; Han SJ; Koh H; Kim S; Lee MJ
World J Gastroenterol; 2019 Jan; 25(3):367-377. PubMed ID: 30686904
[TBL] [Abstract][Full Text] [Related]
16. Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
Sharpton SR; Oh TG; Madamba E; Wang C; Yu RT; Atkins AR; Huan T; Downes M; Evans RM; Loomba R
Aliment Pharmacol Ther; 2022 Nov; 56(10):1475-1485. PubMed ID: 36164267
[TBL] [Abstract][Full Text] [Related]
17. Acoustic radiation force impulse to measure liver stiffness and predict hepatic decompensation in pregnancy with cirrhosis: A cohort study.
Elshaarawy O; Abdelaziz R; Zayed N; Hany A; Hammam Z; Mueller S; Yosry A; Shousha HI
Arab J Gastroenterol; 2022 May; 23(2):89-94. PubMed ID: 35153176
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
[TBL] [Abstract][Full Text] [Related]
20. Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis.
Osman KT; Maselli DB; Idilman IS; Rowan DJ; Viehman JK; Harmsen WS; Harnois DM; Carey EJ; Gossard AA; LaRusso NF; Lindor KD; Venkatesh SK; Eaton JE
J Clin Gastroenterol; 2021 May-Jun 01; 55(5):449-457. PubMed ID: 32976197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]